The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province

Henan Cancer Hospital

Status: Unknown

Conditions: Gastric Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03478943

Ahead-HAT01

Details and patient eligibility

About

The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Male or female patients .
2. Confirmed by Pathology or histology of Gastric cancer.
3. Patients should be voluntary to the trial and provide with signed informed consent.
4. The researchers believe patients can benefit from the study.

Exclusion criteria

1. Patients with a known history of allergic reactions and/or hypersensitivity attributed to apatinib or its accessories.
2. Pregnant or lactating women.
3. Patients with Apatinib contraindications.
4. Patients of doctors considered unsuitable for the trial.